SCHEMBL4473252

SCHEMBL4473252

CCCCc1ccno1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5175178 0.94 CYP1A2 (0.42)
SCHEMBL31287865 0.92 KCNH2 (0.42)
SCHEMBL11892701 0.86
SCHEMBL2089074 0.78 CYP1A2 (0.37)
SCHEMBL2089072 0.74 CYP1A2 (0.33)
SCHEMBL16068283 0.73
SCHEMBL358647 0.73
SCHEMBL11513503 0.73
SCHEMBL21186379 0.70 PRSS1 (0.38)
SCHEMBL4312689 0.69 ALOX5 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3453707-B1 BENZAZEPINE DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI DE NOVO PHARMATECH CO LTD (CN) 2022-02-16 EP disclosed
EP-3558955-B1 BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER AMGEN INC (US) 2021-08-11 EP disclosed
EP-3453707-A1 BENZAZEPINE DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai de Novo Pharmatech Co., Ltd. (CN) 2019-03-13 EP disclosed
EP-1934238-B1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME MELINTA THERAPEUTICS INC (US) 2017-06-28 EP disclosed
CN-102639539-A Process for the preparation of imidazo [2,1-b ] [1,3] benzothiazole derivatives AMBIT BIOSCIENCES CORP 2012-08-15 CN disclosed
US-7576094-B2 Spiro derivatives as lipoxygenase inhibitors ELI LILLY AND COMPANY (US) 2009-08-18 US disclosed
EP-1856079-A4 SPIRO-HETEROCYCLIC CHROMANS, THIOCHROMANS AND DIHYDROQUINOLINES GALILEO PHARMACEUTICALS INC (US) 2008-12-31 EP disclosed
US-20080207588-A1 Spiro-Heterocyclic Chromans, Thiochromans and Dihydroquinolines CHU DANIEL T W 2008-08-28 US disclosed
CN-101163687-A Spiro-heterocyclic chromans, thiochromans and dihydroquinolines GALILEO PHARMACEUTICALS INC (US) 2008-04-16 CN disclosed
EP-1856079-A1 SPIRO-HETEROCYCLIC CHROMANS, THIOCHROMANS AND DIHYDROQUINOLINES Galileo Pharmaceuticals, Inc. (US) 2007-11-21 EP disclosed
EP-1856040-A2 NOVEL LIPOXYGENASE INHIBITORS Eli Lilly and Company (US) 2007-11-21 EP disclosed
EP-1836183-A2 SPIRO DERIVATIVES AS LIPOXYGENASE INHIBITORS Galileo Pharmaceuticals, Inc. (US) 2007-09-26 EP disclosed
WO-2006093548-A1 SPIRO-HETEROCYCLIC CHROMANS, THIOCHROMANS AND DIHYDROQUINOLINES GALILEO PHARMACEUTICALS, INC. (US) 2006-09-08 WO disclosed
WO-2006093547-A2 NOVEL LIPOXYGENASE INHIBITORS ELI LILLY AND COMPANY (US) 2006-09-08 WO disclosed
US-20060193797-A1 Chroman derivatives as lipoxygenase inhibitors GALILEO PHARMACEUTICALS, INC 2006-08-31 US disclosed
WO-2006065686-A2 SPIRO DERIVATIVES AS LIPOXYGENASE INHIBITORS GALILEO PHARMACEUTICALS, INC. (US) 2006-06-22 WO disclosed
US-20060128790-A1 Spiro derivatives as lipoxygenase inhibitors GALILEO PHARMACEUTICALS, INC. 2006-06-15 US disclosed
CN-1213658-C Pyridinecarboxamide derivative and pest control agent containing same as active ingredient MEIJI SEIKA KAISHA (JP) 2005-08-10 CN disclosed
CN-1329596-A Pyridinecarboxamide derivative and pest control agent containing same as active ingredient MEIJI SEIKA KAISHA (JP) 2002-01-02 CN disclosed